Literature DB >> 21160573

Oxidative status and cardiovascular risk in women: Keeping pink at heart.

Cristina Vassalle1, Antonella Mercuri, Silvia Maffei.   

Abstract

Although cardiovascular disease (CVD) has always been perceived as a pathology regarding essentially males, incidence and death from cardiovascular events dramatically increase after menopause in women. Obviously, while many aspects of CVD are similar in both sexes, it is now clear that there are significant differences as well. Exploration of these gender-related differences in CVD might provide a basis for the development of new strategies in the management of patients with CVD from a gender point of view. In particular, a growing amount of data suggested the possible major role of oxidative stress in female patients and the possibility to integrate this new biomarker in future study evaluating CVD risk in women.

Entities:  

Keywords:  Cardiovascular; Gender; Menopause; Oxidative stress; Risk factors; Women

Year:  2009        PMID: 21160573      PMCID: PMC2998800          DOI: 10.4330/wjc.v1.i1.26

Source DB:  PubMed          Journal:  World J Cardiol


  40 in total

1.  Gender differences in the treatment for acute myocardial infarction: bias or biology?

Authors:  R David Anderson; Carl J Pepine
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

Review 2.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

Authors:  Lori Mosca; Carole L Banka; Emelia J Benjamin; Kathy Berra; Cheryl Bushnell; Rowena J Dolor; Theodore G Ganiats; Antoinette S Gomes; Heather L Gornik; Clarissa Gracia; Martha Gulati; Constance K Haan; Debra R Judelson; Nora Keenan; Ellie Kelepouris; Erin D Michos; L Kristin Newby; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Diana Petitti; Vivian W Pinn; Rita F Redberg; Rosalyn Scott; Katherine Sherif; Sidney C Smith; George Sopko; Robin H Steinhorn; Neil J Stone; Kathryn A Taubert; Barbara A Todd; Elaine Urbina; Nanette K Wenger
Journal:  Circulation       Date:  2007-02-19       Impact factor: 29.690

3.  Increase with age of serum lipid peroxides: implications for the prevention of atherosclerosis.

Authors:  J Miquel; A Ramirez-Boscá; A Soler; A Díez; M A Carrión-Gutiérrez; J Díaz-Alperi; E Quintanilla-Ripoll; A Bernd; E Quintanilla-Almagro
Journal:  Mech Ageing Dev       Date:  1998-01-12       Impact factor: 5.432

4.  Low concentrations of 17beta-estradiol reduce oxidative modification of low-density lipoproteins in the presence of vitamin C and vitamin E.

Authors:  M Huang; J Li; H Teoh; R Y Man
Journal:  Free Radic Biol Med       Date:  1999-08       Impact factor: 7.376

5.  Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.

Authors:  S Maffei; A Mercuri; C Prontera; G C Zucchelli; C Vassalle
Journal:  Climacteric       Date:  2006-12       Impact factor: 3.005

6.  Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.

Authors:  Akio Kikuchi; Atsushi Takeda; Hiroshi Onodera; Teiko Kimpara; Kinya Hisanaga; Nobuyuki Sato; Akihiko Nunomura; Rudy J Castellani; George Perry; Mark A Smith; Yasuto Itoyama
Journal:  Neurobiol Dis       Date:  2002-03       Impact factor: 5.996

7.  Gender-Based Differences in Leptinemia in Healthy Aging, Non-obese Individuals Associate with Increased Marker of Oxidative Stress.

Authors:  Anshu Agrawal; Elaine V Lourenço; Sudhir Gupta; Antonio La Cava
Journal:  Int J Clin Exp Med       Date:  2008-08-12

8.  Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.

Authors:  Giuseppe M C Rosano; Silvia Maffei; Maria G Andreassi; Cristiana Vitale; Cristina Vassalle; Marco Gambacciani; Marco Stramba-Badiale; Giuseppe Mercuro
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-01       Impact factor: 2.160

9.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

10.  Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation.

Authors:  Francesco Grassi; Gianluca Tell; Michaela Robbie-Ryan; Yuhao Gao; Masakazu Terauchi; Xiaoying Yang; Milena Romanello; Dean P Jones; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

View more
  6 in total

Review 1.  G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease.

Authors:  Guichun Han; Richard E White
Journal:  World J Cardiol       Date:  2014-06-26

2.  Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?

Authors:  Paulo J Oliveira; Rui A Carvalho; Piero Portincasa; Leonilde Bonfrate; Vilma A Sardao
Journal:  J Lipids       Date:  2012-02-01

Review 3.  Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide?

Authors:  Cristina Vassalle; Annamaria Mazzone; Laura Sabatino; Clara Carpeggiani
Journal:  Diseases       Date:  2016-02-26

Review 4.  Is Extra Virgin Olive Oil an Ally for Women's and Men's Cardiovascular Health?

Authors:  Flavia Franconi; Ilaria Campesi; Annalisa Romani
Journal:  Cardiovasc Ther       Date:  2020-04-24       Impact factor: 3.023

5.  Efficacy of a low dose of estrogen on antioxidant defenses and heart rate variability.

Authors:  Cristina Campos; Karina Rabello Casali; Dhãniel Baraldi; Adriana Conzatti; Alex Sander da Rosa Araújo; Neelam Khaper; Susana Llesuy; Katya Rigatto; Adriane Belló-Klein
Journal:  Oxid Med Cell Longev       Date:  2014-03-10       Impact factor: 6.543

6.  Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN.

Authors:  Somak Das; Goran Mitrovsky; Hannah R Vasanthi; Dipak K Das
Journal:  Oxid Med Cell Longev       Date:  2014-01-12       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.